The ALS Therapy Development Institute (ALS TDI) is
offering the opportunity to participate as an official entrant in
the 2026 Schneider Electric Marathon de Paris:
or
{{mt.Name}}
to be held Sunday, April 12, 2026. Before completing the
application form below, it is important to note that there is a fundraising minimum
or ({{mt.Name}}: {{mt.FundraisingMinimum|currency:$:0}})
required of the successful applicant. Those funds support ALS TDI's mission to find effective
treatments and cures for Amyotrophic Lateral Sclerosis (ALS).
the 2026 Schneider Electric Marathon de Paris Marathon to be held Sunday, April 12, 2026.
Before completing the application form below, it is important to note that there is a
{{details.Details.MarathonTypes[0].FundraisingMinimum|currency:$:0}} fundraising minimum required of the
successful applicant. Those funds support ALS TDI's mission to find effective treatments and
cures for Amyotrophic Lateral Sclerosis (ALS).
ABOUT THE ALS THERAPY DEVELOPMENT INSTITUTE (ALS TDI)
ALS TDI is the world's foremost drug discovery center focused solely on Amyotrophic Lateral Sclerosis (ALS). As a nonprofit biotech, its Watertown, MA-based science team actively discovers and develops treatments for ALS. Led by people with ALS and drug development experts, ALS TDI understands the urgent need to slow and stop this disease.
Visit www.als.net for more information.
ABOUT ALS
Amyotrophic lateral sclerosis (ALS), also known as Motor Neuron Disease (MND), Lou Gehrig's Disease, and Charcot's disease, is a disease of the nerve cells in the brain and spinal cord that control voluntary muscle movement. In people with ALS, the motor neurons deteriorate leading to muscle weakness and paralysis. Every 90 minutes, someone is diagnosed with ALS, and most people live 2-5 years after their first signs of disease. There is no effective treatment or cure.
FUNDRAISING MINIMUM
The minimum fundraising requirement1 is:
or ({{mt.Name}}: {{mt.FundraisingMinimum|currency}})
and must be reached by Sunday, April 12, 2026.
Any outstanding balance will be charged by ALS TDI using the entrant's credit card on file on
{{details.Details.FundraisingBalanceDate|aspDate|date:'fullDate'}}.
The minimum fundraising requirement is
{{details.Details.MarathonTypes[0].FundraisingMinimum|currency:$:0}}1
and must be reached by Sunday, April 12, 2026.
Any outstanding balance will be charged by ALS TDI using the entrant's credit card on file on
{{details.Details.FundraisingBalanceDate|aspDate|date:'fullDate'}}.
BENEFITS OF RUNNING THE {{details.FullName|uppercase}} FOR ALS TDI
ALS TDI offers the following benefits to the successful applicant:
APPLICATION DEADLINE
Please complete and submit this application by {{details.Details.ApplicationDeadlineDate|aspDate|date:'fullDate'}},
to be considered. Successful applicants will be chosen by internal selection committee, and notified no later than
{{details.Details.NotificationDate|aspDate|date:'fullDate'}}.
1
While there is the minimum fundraising requirement, it
is our mission to develop treatments for ALS as quickly as possible, and thus we will take note of those
applicants with a strategy to raise funds beyond the minium fundraising amount.
While {{details.Details.MarathonTypes[0].FundraisingMinimum|currency:$:0}} is the minimum fundraising requirement, it
is our mission to develop treatments for ALS as quickly as possible, and thus we will take note of those
applicants with a strategy to raise funds beyond {{details.Details.MarathonTypes[0].FundraisingMinimum|currency:$:0}}.